Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Citrin

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Medicine|May 1, 1984
Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implicationsD L Citrin, P Elson, M S Kies, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1975
Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumorsD L Citrin, R G Bessent, E McGinley, et al.
Cancer Treatment Reports|July 1, 1981
Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluationA I Cohen, J Koeller, T E Davis, et al.
Wisconsin Medical Journal|October 1, 1978
Radiation-induced carcinoma of the thyroid with severe thyrotoxicosisD L Citrin, J Pederson, D P Rose, et al.
Cancer|June 1, 1980
A clinical and pathological study of adrenocortical carcinoma: therapeutic implicationsT F Hogan, K W Gilchrist, D W Westring, et al.
Scottish Medical Journal|May 1, 1974
Evaluation of radioactive labelled phosphates in diagnosis of skeletal metastasesD L Citrin, R G Bessent, W R Greig, et al.
Proceedings of the Royal Society of Medicine|June 1, 1975
Early detection of metastatic breast cancer using new bone scanning agentsD L Citrin, R G Bessent, L H Blumgart, et al.
European Journal of Nuclear Medicine|January 1, 1978
A clinical comparison of 2 h and 4 h bone scans obtained with 99Tc H.E.D.PI Fogelman, C Goll, J H McKillop, et al.
The Journal of Urology|February 1, 1981
Systemic treatment of advanced prostatic cancer: development of a new system for defining responseD L Citrin, A I Cohen, J Harberg, et al.
British Journal of Cancer|January 1, 1974
Proceedings: A comparison of phosphate bone scanning agents in human malignant diseaseD L Citrin, R Bessent, J Tuohy, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Medicine|May 1, 1984
Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implicationsD L Citrin, P Elson, M S Kies, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1975
Dynamic studies with 99mTc-HEDP in normal subjects and in patients with bone tumorsD L Citrin, R G Bessent, E McGinley, et al.
Cancer Treatment Reports|July 1, 1981
Iv dichloromethylene diphosphonate in cancer-associated hypercalcemia: a phase I-II evaluationA I Cohen, J Koeller, T E Davis, et al.
Wisconsin Medical Journal|October 1, 1978
Radiation-induced carcinoma of the thyroid with severe thyrotoxicosisD L Citrin, J Pederson, D P Rose, et al.
Cancer|June 1, 1980
A clinical and pathological study of adrenocortical carcinoma: therapeutic implicationsT F Hogan, K W Gilchrist, D W Westring, et al.
Scottish Medical Journal|May 1, 1974
Evaluation of radioactive labelled phosphates in diagnosis of skeletal metastasesD L Citrin, R G Bessent, W R Greig, et al.
Proceedings of the Royal Society of Medicine|June 1, 1975
Early detection of metastatic breast cancer using new bone scanning agentsD L Citrin, R G Bessent, L H Blumgart, et al.
European Journal of Nuclear Medicine|January 1, 1978
A clinical comparison of 2 h and 4 h bone scans obtained with 99Tc H.E.D.PI Fogelman, C Goll, J H McKillop, et al.
The Journal of Urology|February 1, 1981
Systemic treatment of advanced prostatic cancer: development of a new system for defining responseD L Citrin, A I Cohen, J Harberg, et al.
British Journal of Cancer|January 1, 1974
Proceedings: A comparison of phosphate bone scanning agents in human malignant diseaseD L Citrin, R Bessent, J Tuohy, et al.
Pageof 6